Management of vertebral radiotherapy dose in paediatric patients with cancer

Standard

Management of vertebral radiotherapy dose in paediatric patients with cancer : consensus recommendations from the SIOPE radiotherapy working group. / Hoeben, Bianca A; Carrie, Christian; Timmermann, Beate; Mandeville, Henry C; Gandola, Lorenza; Dieckmann, Karin; Ramos Albiac, Monica; Magelssen, Henriette; Lassen-Ramshad, Yasmin; Ondrová, Barbora; Ajithkumar, Thankamma; Alapetite, Claire; Balgobind, Brian V; Bolle, Stephanie; Cameron, Alison L; Davila Fajardo, Raquel; Dietzsch, Stefan; Dumont Lecomte, Delphine; van den Heuvel-Eibrink, Marry M; Kortmann, Rolf D; Laprie, Anne; Melchior, Patrick; Padovani, Laetitia; Rombi, Barbara; Scarzello, Giovanni; Schwarz, Rudolf; Seiersen, Klaus; Seravalli, Enrica; Thorp, Nicola; Whitfield, Gillian A; Boterberg, Tom; Janssens, Geert O.

In: LANCET ONCOL, Vol. 20, No. 3, 03.2019, p. e155-e166.

Research output: SCORING: Contribution to journalSCORING: Review articleResearch

Harvard

Hoeben, BA, Carrie, C, Timmermann, B, Mandeville, HC, Gandola, L, Dieckmann, K, Ramos Albiac, M, Magelssen, H, Lassen-Ramshad, Y, Ondrová, B, Ajithkumar, T, Alapetite, C, Balgobind, BV, Bolle, S, Cameron, AL, Davila Fajardo, R, Dietzsch, S, Dumont Lecomte, D, van den Heuvel-Eibrink, MM, Kortmann, RD, Laprie, A, Melchior, P, Padovani, L, Rombi, B, Scarzello, G, Schwarz, R, Seiersen, K, Seravalli, E, Thorp, N, Whitfield, GA, Boterberg, T & Janssens, GO 2019, 'Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group', LANCET ONCOL, vol. 20, no. 3, pp. e155-e166. https://doi.org/10.1016/S1470-2045(19)30034-8

APA

Hoeben, B. A., Carrie, C., Timmermann, B., Mandeville, H. C., Gandola, L., Dieckmann, K., Ramos Albiac, M., Magelssen, H., Lassen-Ramshad, Y., Ondrová, B., Ajithkumar, T., Alapetite, C., Balgobind, B. V., Bolle, S., Cameron, A. L., Davila Fajardo, R., Dietzsch, S., Dumont Lecomte, D., van den Heuvel-Eibrink, M. M., ... Janssens, G. O. (2019). Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group. LANCET ONCOL, 20(3), e155-e166. https://doi.org/10.1016/S1470-2045(19)30034-8

Vancouver

Bibtex

@article{1d1cba76023c4214a29d0683c595d85e,
title = "Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group",
abstract = "Inhomogeneities in radiotherapy dose distributions covering the vertebrae in children can produce long-term spinal problems, including kyphosis, lordosis, scoliosis, and hypoplasia. In the published literature, many often interrelated variables have been reported to affect the extent of potential radiotherapy damage to the spine. Articles published in the 2D and 3D radiotherapy era instructed radiation oncologists to avoid dose inhomogeneity over growing vertebrae. However, in the present era of highly conformal radiotherapy, steep dose gradients over at-risk structures can be generated and thus less harm is caused to patients. In this report, paediatric radiation oncologists from leading centres in 11 European countries have produced recommendations on how to approach dose coverage for target volumes that are adjacent to vertebrae to minimise the risk of long-term spinal problems. Based on available information, it is advised that homogeneous vertebral radiotherapy doses should be delivered in children who have not yet finished the pubertal growth spurt. If dose fall-off within vertebrae cannot be avoided, acceptable dose gradients for different age groups are detailed here. Vertebral delineation should include all primary ossification centres and growth plates, and therefore include at least the vertebral body and arch. For partial spinal radiotherapy, the number of irradiated vertebrae should be restricted as much as achievable, particularly at the thoracic level in young children (<6 years old). There is a need for multicentre research on vertebral radiotherapy dose distributions for children, but until more valid data become available, these recommendations can provide a basis for daily practice for radiation oncologists who have patients that require vertebral radiotherapy.",
author = "Hoeben, {Bianca A} and Christian Carrie and Beate Timmermann and Mandeville, {Henry C} and Lorenza Gandola and Karin Dieckmann and {Ramos Albiac}, Monica and Henriette Magelssen and Yasmin Lassen-Ramshad and Barbora Ondrov{\'a} and Thankamma Ajithkumar and Claire Alapetite and Balgobind, {Brian V} and Stephanie Bolle and Cameron, {Alison L} and {Davila Fajardo}, Raquel and Stefan Dietzsch and {Dumont Lecomte}, Delphine and {van den Heuvel-Eibrink}, {Marry M} and Kortmann, {Rolf D} and Anne Laprie and Patrick Melchior and Laetitia Padovani and Barbara Rombi and Giovanni Scarzello and Rudolf Schwarz and Klaus Seiersen and Enrica Seravalli and Nicola Thorp and Whitfield, {Gillian A} and Tom Boterberg and Janssens, {Geert O}",
note = "Copyright {\textcopyright} 2019 Elsevier Ltd. All rights reserved.",
year = "2019",
month = mar,
doi = "10.1016/S1470-2045(19)30034-8",
language = "English",
volume = "20",
pages = "e155--e166",
journal = "LANCET ONCOL",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "3",

}

RIS

TY - JOUR

T1 - Management of vertebral radiotherapy dose in paediatric patients with cancer

T2 - consensus recommendations from the SIOPE radiotherapy working group

AU - Hoeben, Bianca A

AU - Carrie, Christian

AU - Timmermann, Beate

AU - Mandeville, Henry C

AU - Gandola, Lorenza

AU - Dieckmann, Karin

AU - Ramos Albiac, Monica

AU - Magelssen, Henriette

AU - Lassen-Ramshad, Yasmin

AU - Ondrová, Barbora

AU - Ajithkumar, Thankamma

AU - Alapetite, Claire

AU - Balgobind, Brian V

AU - Bolle, Stephanie

AU - Cameron, Alison L

AU - Davila Fajardo, Raquel

AU - Dietzsch, Stefan

AU - Dumont Lecomte, Delphine

AU - van den Heuvel-Eibrink, Marry M

AU - Kortmann, Rolf D

AU - Laprie, Anne

AU - Melchior, Patrick

AU - Padovani, Laetitia

AU - Rombi, Barbara

AU - Scarzello, Giovanni

AU - Schwarz, Rudolf

AU - Seiersen, Klaus

AU - Seravalli, Enrica

AU - Thorp, Nicola

AU - Whitfield, Gillian A

AU - Boterberg, Tom

AU - Janssens, Geert O

N1 - Copyright © 2019 Elsevier Ltd. All rights reserved.

PY - 2019/3

Y1 - 2019/3

N2 - Inhomogeneities in radiotherapy dose distributions covering the vertebrae in children can produce long-term spinal problems, including kyphosis, lordosis, scoliosis, and hypoplasia. In the published literature, many often interrelated variables have been reported to affect the extent of potential radiotherapy damage to the spine. Articles published in the 2D and 3D radiotherapy era instructed radiation oncologists to avoid dose inhomogeneity over growing vertebrae. However, in the present era of highly conformal radiotherapy, steep dose gradients over at-risk structures can be generated and thus less harm is caused to patients. In this report, paediatric radiation oncologists from leading centres in 11 European countries have produced recommendations on how to approach dose coverage for target volumes that are adjacent to vertebrae to minimise the risk of long-term spinal problems. Based on available information, it is advised that homogeneous vertebral radiotherapy doses should be delivered in children who have not yet finished the pubertal growth spurt. If dose fall-off within vertebrae cannot be avoided, acceptable dose gradients for different age groups are detailed here. Vertebral delineation should include all primary ossification centres and growth plates, and therefore include at least the vertebral body and arch. For partial spinal radiotherapy, the number of irradiated vertebrae should be restricted as much as achievable, particularly at the thoracic level in young children (<6 years old). There is a need for multicentre research on vertebral radiotherapy dose distributions for children, but until more valid data become available, these recommendations can provide a basis for daily practice for radiation oncologists who have patients that require vertebral radiotherapy.

AB - Inhomogeneities in radiotherapy dose distributions covering the vertebrae in children can produce long-term spinal problems, including kyphosis, lordosis, scoliosis, and hypoplasia. In the published literature, many often interrelated variables have been reported to affect the extent of potential radiotherapy damage to the spine. Articles published in the 2D and 3D radiotherapy era instructed radiation oncologists to avoid dose inhomogeneity over growing vertebrae. However, in the present era of highly conformal radiotherapy, steep dose gradients over at-risk structures can be generated and thus less harm is caused to patients. In this report, paediatric radiation oncologists from leading centres in 11 European countries have produced recommendations on how to approach dose coverage for target volumes that are adjacent to vertebrae to minimise the risk of long-term spinal problems. Based on available information, it is advised that homogeneous vertebral radiotherapy doses should be delivered in children who have not yet finished the pubertal growth spurt. If dose fall-off within vertebrae cannot be avoided, acceptable dose gradients for different age groups are detailed here. Vertebral delineation should include all primary ossification centres and growth plates, and therefore include at least the vertebral body and arch. For partial spinal radiotherapy, the number of irradiated vertebrae should be restricted as much as achievable, particularly at the thoracic level in young children (<6 years old). There is a need for multicentre research on vertebral radiotherapy dose distributions for children, but until more valid data become available, these recommendations can provide a basis for daily practice for radiation oncologists who have patients that require vertebral radiotherapy.

U2 - 10.1016/S1470-2045(19)30034-8

DO - 10.1016/S1470-2045(19)30034-8

M3 - SCORING: Review article

C2 - 30842059

VL - 20

SP - e155-e166

JO - LANCET ONCOL

JF - LANCET ONCOL

SN - 1470-2045

IS - 3

ER -